Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

BACKGROUND: Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is possible to harness the physiological proper...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohsen, Mona O., Heath, Matthew D., Cabral-Miranda, Gustavo, Lipp, Cyrill, Zeltins, Andris, Sande, Marcos, Stein, Jens V., Riether, Carsten, Roesti, Elisa, Zha, Lisha, Engroff, Paul, El-Turabi, Aadil, Kundig, Thomas M., Vogel, Monique, Skinner, Murray A., Speiser, Daniel E., Knuth, Alexander, Kramer, Matthias F., Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485085/
https://www.ncbi.nlm.nih.gov/pubmed/31027511
http://dx.doi.org/10.1186/s40425-019-0587-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485085/
https://www.ncbi.nlm.nih.gov/pubmed/31027511
http://dx.doi.org/10.1186/s40425-019-0587-z

Ejemplares similares